WASHINGTON — The Food and Drug Administration is working with nine heath companies to learn more about medical software development so that the agency can consider allowing companies to sell software with less, or perhaps, no evaluation of the software itself before it goes to market, the agency announced Tuesday.

The nine companies, whose products range from fitness trackers to diagnostic test development, are helping the FDA develop a pre-certification program, dubbed “FDA Pre-cert,” which would shift the agency’s focus from evaluating products to evaluating producers. If a company demonstrates that it meets certain to-be-determined markers of quality, then it could be subject to less regulation.

This is a STAT Plus article and you can unlock it by subscribing to STAT Plus today. It's easy! Your first 30 days are free and if you don't enjoy your subscription you can cancel any time.
Already a subscriber? Log in here.

Sign up for our Morning Rounds newsletter

Your daily dose of what’s new in health and medicine.